Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized open-label multicenter trial of rhPTH(1-34) in primary osteoporosis
ChiCTR-TRC-10000924Phase 2Completed
- Sponsor
- Tongji Hospital
- Start
- Oct 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of teriparatide in involutional osteoporosis (2 arms), sponsored by Tongji Hospital. Primary endpoints: Change in bone mineral density and Bone-specific alkaline phosphatase. Started Oct 2006; status: completed.
02
Drugs
teriparatide
03
Conditions
involutional osteoporosis
Beyond the preview
Go deeper on ChiCTR-TRC-10000924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000924.